联合患者报告结局指标筛查类风湿关节炎与银屑病关节炎的活动性疾病
研究纳入tREACH与TARA试验的683例类风湿关节炎(RA)患者及DEPAR队列的525例银屑病关节炎(PsA)患者,评估一般健康(VAS)、HAQ-DI、疼痛、EQ-5D、疲劳及出勤主义恶化与活动性疾病的关系。RA与PsA中一般健康、HAQ-DI、EQ-5D和疼痛恶化均与活动性疾病显著相关,联合AUC分别为0.76和0.85。作者认为该组合可辅助筛查活动性疾病并有助于未来远程监测。
要点
- RA中一般健康、HAQ-DI、EQ-5D和疼痛恶化与活动性疾病显著相关,联合AUC=0.76。
- PsA中上述指标恶化亦与活动性疾病显著相关,联合AUC=0.85。
- 以≥1项PROM恶化为切点时,RA特异性40%、敏感性90%;PsA特异性41%、敏感性4%。
核心结论
- 一般健康、HAQ-DI、EQ-5D和疼痛的组合可辅助作为RA和PsA活动性疾病的筛查工具。
- 这些数据可能有助于未来促进RA和PsA患者的远程监测。
研究设计与样本
- RA患者来自tREACH试验和TARA试验(n=683),PsA患者来自DEPAR队列(n=525)。
- 评估两次连续访视间上述PROM评分恶化与活动性疾病的相关性。
- 活动性疾病定义为RA中DAS从≤2.4变为>2.4,或PsA中DAPSA从≤14变为>14。
- 评估恶化的PROM总和评分的曲线下面积(AUC)。
主要发现
- 共评估4594次RA访视和1154次PsA访视,活动性疾病分别发生于358次(8%)RA访视和177次(15%)PsA访视。
- RA和PsA中,一般健康(VAS)、HAQ-DI、EQ-5D和疼痛(VAS/NRS)的恶化均与活动性疾病显著相关。
- 上述PROM组合的判别能力为可接受到优秀(RA AUC=0.76,PsA AUC=0.85)。
- 以≥1项PROM恶化为切点时,RA中40%的缓解或低疾病活动度访视被正确判定(特异性40%),10%的活动性疾病访视被遗漏(敏感性90%)。
- PsA中上述比例分别为41%和4%。
关键数值与推荐
- 活动性疾病定义:RA为DAS从≤2.4变为>2.4;PsA为DAPSA从≤14变为>14。
- RA联合PROM的AUC=0.76,PsA联合PROM的AUC=0.85。
- 切点≥1项PROM恶化时,RA特异性40%、敏感性90%;PsA特异性41%、敏感性4%。
临床怎么用
- 作者认为一般健康、HAQ-DI、EQ-5D和疼痛的组合可辅助作为RA和PsA活动性疾病的筛查工具。
- 作者认为这些数据可能有助于未来促进RA和PsA患者的远程监测。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To investigate whether a combination of general health (Visual Analogue Scale (VAS)), Health Assessment Questionnaire-Disability Index (HAQ-DI), pain (VAS/Numerical Rating Scale (NRS)), quality of life (EQ-5D), fatigue (VAS/NRS) and presenteeism (0%-100% productivity loss) could aid as a screening tool to detect active disease in patients with rheumatoid arthritis (RA) and psoriatic arthritis (PsA). METHODS: RA patients from the tREACH trial and TARA trial (n=683) and PsA patients from the DEPAR cohort (n=525) were included. The association of a deterioration in the aforementioned patient-reported outcome measure (PROM) scores between two consecutive visits and having active disease was assessed. Active disease was defined as a change from disease activity score (DAS) ≤2.4 to DAS >2.4 in RA or Disease Activity Index in Psoriatic Arthritis (DAPSA) ≤14 to DAPSA >14 in PsA. The area under the curve (AUC) of the sum score of deteriorated PROMs was evaluated. RESULTS: 4594 RA and 1154 PsA visits were evaluated and active disease occurred in 358 (8%) RA and 177 (15%) PsA visits. In both RA and PsA, a deterioration in general health (VAS), HAQ-DI, EQ-5D and pain (VAS/NRS) was significantly associated with active disease. The combination of these PROMs showed acceptable to excellent discriminative ability (RA AUC=0.76, PsA AUC=0.85). If a cut-point of ≥1 deteriorated PROMs is used, 40% of the visits in which RA patients have remission or low disease activity are correctly specified (specificity of 40%), while 10% of visits with active disease are overlooked (sensitivity of 90%). In PsA, these percentages are 41% and 4%, respectively. CONCLUSION: A combination of general health, HAQ-DI, EQ-5D and pain could aid as a screening tool for active disease in patients with RA and PsA. These data could help facilitate remote monitoring of RA and PsA patients in the future. TRIAL REGISTRATION NUMBERS: ISRCTN26791028, NTR2754.
引用
- Looijen AEM, Snoeck Henkemans SVJ, van der Helm-van Mil AHM, et al. Combining patient-reported outcome measures to screen for active disease in rheumatoid arthritis and psoriatic arthritis. RMD Open. 2024. PMID: 39424407. doi:10.1136/rmdopen-2024-004687
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。